Thus, epothilone A was selected for in vitro glycosylation in the current study because it has high demand in the cancer therapeutic development possessing high cytotoxic effects in taxane sensitive cell lines including P-glycoprotein overexpression (Cortes et al. [2012]). This evidence concerns the gene ABCB1 and cancer.